Abstracts tagged "Epidemiologic methods and gout"

Abstract Number: 2226 • 2018 ACR/ARHP Annual Meeting
Gout and the Risk of Incident Dementia in the Elderly: A Medicare Claims Study
Jasvinder A. Singh¹ and John Cleveland², ¹Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ²University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The pursuit of a link between gout/hyperuricemia and dementia has led to contradictory results. Most observational studies, including population-based studies, showed that hyperuricemia was…
Abstract Number: 2306 • 2016 ACR/ARHP Annual Meeting
Improving Predictive Value of Gout Case Definitions in Electric Medical Records Utilizing Natural Language Processing: a Novel Informatics Approach
Sian Yik Lim¹, Sara R. Schoenfeld², Abhishek Chakrabortty³, Tianxi Cai³, Andrew Cagan⁴, Vivian Gainer⁵ and Hyon K. Choi⁶, ¹Rheumatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Rheumatology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Department of Biostatistics, Harvard Medical School, Boston, MA, ⁴Research Computing, Partners HealthCare, Charlestown, MA, ⁵Partners HealthCare, Boston, MA, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: To date, most of the models used to identify gout cases within large administrative databases have relied solely only on administrative billing codes. The…
Abstract Number: 2094 • 2015 ACR/ARHP Annual Meeting
Identification of Gout Flare Using an Administrative Claims Based Algorithm
Lindsey MacFarlane¹, Daniel H. Solomon¹ and Seoyoung C. Kim², ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Division of Rheumatology; Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Gout is a common inflammatory arthritis characterized by repeated acute flares. The ability to accurately identify gout flares is critical for comparative effectiveness studies…
Abstract Number: 1998 • 2013 ACR/ARHP Annual Meeting
The Risk Of Subsequent Attacks In Patients With Incident Gout: A Population-Based Study
Nour Zleik¹, Clement J. Michet¹, Helen Khun², Cynthia S. Crowson², Eric L. Matteson¹ and Tim Bongartz¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: While there appears to be consensus that non-pharmacological uric acid lowering therapies (diet and lifestyle modifications) should be initiated in every patient presenting with…
Abstract Number: 1999 • 2013 ACR/ARHP Annual Meeting
Hospitalization and Flare Risk In Patients With Established Gout: A Population-Based Study
Nour Zleik¹, Clement J. Michet¹, Helen Khun², Cynthia S. Crowson², Eric L. Matteson¹ and Tim Bongartz¹, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: Hospitalization of patients with gout may be associated with an increased risk of arthritic flares, due to administration of IV fluids, discontinuation of established…
Abstract Number: 164 • 2012 ACR/ARHP Annual Meeting
The Prevalence of Gout in a Large Tertiary Hospital and the Impact of in-Hospital Attacks of Acute Gout On Patient Outcomes and Health Resource Utilisation – a Nested Case-Control Study
John HY Moi¹, Mark Tacey², Carol Roberts³, Caroline Brand², Alexandra Gorelik³ and Sharon Van Doornum², ¹Department of Rheumatology, Department of Medicine (RMH), The Royal Melbourne Hospital, The University of Melbourne, Melbourne, Australia, ²Melbourne EpiCentre, The University of Melbourne, Melbourne, Australia, ³Melbourne EpiCentre, The Royal Melbourne Hospital, Melbourne, Australia
Background/Purpose: Acute gout can develop in hospitalised patients either as a new event or as a recurrence of established disease. To date there have been…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].